Masano Sagawa

Dr. Masano Sagawa

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in Annals of Surgery
Verified
Journal Article
Open access
Ryota MatsuiRyota Matsui
Ryota Matsui
MSMasano Sagawa
Masano Sagawa
ASAkihiko Sano
Akihiko Sano
MSMakoto Sakai
Makoto Sakai
SHShin-ichiro Hiraoka
Shin-ichiro Hiraoka
JKJoji Kotani
Joji Kotani
Objective: To clarify whether perioperative immunonutrition is effective in adult patients with or without malnutrition undergoing elective surgery for head and neck (HAN) or gastrointestinal (GI) cancers. Background: It is important to avoid postoperative complications in patients with cancer as they can compromise clinical outcomes. There is no consensus on the efficacy of perioperative immunonutrition in patients with or without malnutrition undergoing HAN or GI cancer surgery. Materials and Methods: We searched MEDLINE (PubMed), MEDLINE (OVID), EMBASE, Cochrane Central Register of Controlled Trials, Web of Science Core Selection, and Emcare from 1981 to 2022 using search terms related to immunonutrition and HAN or GI cancer. We included randomized controlled trials. Intervention was defined as immunonutritional therapy including arginine, n-3 omega fatty acids, or glutamine during the perioperative period. The control was defined as standard nutritional therapy. The primary outcomes were total postoperative and infectious complications, defined as events with a Clavien–Dindo classification grade ≥ II that occurred within 30 days after surgery. Results: Of the 4825 patients from 48 included studies, 19 had upper GI cancer, 9 had lower, and 8 had mixed cancer, whereas 12 had HAN cancers. Immunonutrition reduced the total postoperative complications (relative risk ratio: 0.78; 95% CI, 0.66–0.93; certainty of evidence: high) and infectious complications (relative risk ratio: 0.71; 95% CI, 0.61–0.82; certainty of evidence: high) compared with standard nutritional therapy. Conclusions: Nutritional intervention with perioperative immunonutrition in patients with HAN and GI cancers significantly reduced total postoperative complications and infectious complications.

20 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Ryota MatsuiRyota Matsui
Ryota Matsui
MSMasano Sagawa
Masano Sagawa
Noriyuki InakiNoriyuki Inaki
Noriyuki Inaki
TFTetsu Fukunaga
Tetsu Fukunaga
SNSouya Nunobe
Souya Nunobe
There is no consensus on the efficacy of perioperative immunonutrition in patients with upper gastrointestinal (GI) cancer surgery. We clarified the impact of perioperative immunonutrition on postoperative outcomes in patients with upper GI cancers. We searched MEDLINE (PubMed), MEDLINE (OVID), EMBASE, Cochrane Central Register of Controlled Trials, Web of Science Core Selection, and Emcare from 1981–2022 using search terms related to immunonutrition and upper GI cancer. We included randomized controlled trials. Intervention was defined as immunonutritional therapy, including arginine, n-3 omega fatty acids, or glutamine during the perioperative period. The control was defined as standard nutritional therapy. The primary outcomes were infectious complications, defined as events with a Clavien–Dindo classification grade ≥ II that occurred within 30 days after surgery. After screening, 23 studies were included in the qualitative synthesis and in the quantitative synthesis. The meta-analysis showed that immunonutrition reduced infectious complications (relative risk ratio: 0.72; 95% confidence interval: 0.57–0.92; certainty of evidence: Moderate) compared with standard nutritional therapy. In conclusion, nutritional intervention with perioperative immunonutrition in patients with upper GI cancers significantly reduced infectious complications. The effect of immunonutrition for upper GI cancers in reducing the risk of infectious complications was about 30%.


28 June 2024 in Medicine
Verified
Journal Article
Open access
HMHideo Matsumoto
Hideo Matsumoto
SOSeiji Onogawa
Seiji Onogawa
NSNorihiro Dds Sonoi
Norihiro Dds Sonoi
MSMasano Sagawa
Masano Sagawa
SWShigeki Wakiyama
Shigeki Wakiyama
JKJoji Kotani
Joji Kotani
Introduction: Healthy eating and weight control are recommended for cancer survivors; however, dietary interventions are not routinely offered to them. This study aimed to assess the effects of dietary interventions on survival, nutritional status, morbidity, dietary changes, health-related quality of life (QOL), and clinical measures in cancer survivors. Methods: Searches were conducted from October 1, 2018 to November 21, 2011 in the Medline, EMBASE, CENTRAL, Emcare, and DARE electronic databases. We included randomized controlled trials (RCTs) that involved individuals diagnosed with cancer, excluding conference abstracts, case studies, other reviews, and meta-analyses, and screened the articles. Results: Eight studies were included in this meta-analysis. We observed significant improvements in QOL and clinical data in 3 of 6 studies and in one study, respectively, significant weight loss on anthropometry in 2 of 5 studies, and dietary improvement in 4 of 5 studies of adult cancer survivors. However, we did not observe any benefits of dietary intervention for cancer survivors with undernutrition. Discussion: Dietary interventions for adult cancer survivors might contribute to improving their nutritional status; however, further clarification requires a study that standardizes the intervention method. Furthermore, RCTs are required to determine the effects on cancer survivors with undernutrition.

1 January 2017 in The Japanese Journal of SURGICAL METABOLISM and NUTRITION
Verified
Journal Article
Open access
PDF file
KYKazuhiko Yoshimatsu
Kazuhiko Yoshimatsu
MSMasano Sagawa
Masano Sagawa
HYHajime Yokomizo
Hajime Yokomizo
YYYuki Yano
Yuki Yano
SOSachiyo Okayama
Sachiyo Okayama
YNYoshihiko Naritaka
Yoshihiko Naritaka
【目的】大腸癌患者における術前のControlling Nutritional Status(CONUT)score の臨床的意義を明らかにする目的で検討した. 【対象と方法】大腸癌切除を施行した351 例を対象に,surgical site infection(SSI)発生との関連からCONUT score cut-off 値をReceiver operating characteristic curve(ROC 曲線)を用いて求め,5 年生存率との関連をみた. 【結果】SSI 発生頻度(≧Grade II)は9.1%(32 例)で,CONUT score cut-off 値は3.0(AUC;0.66,感度63%,特異度74%,95% CI;0.54-0.76)であった.CONUT score>3.0 の5 年生存率は38.5%で,CONUTscore≦3.0 の78.4%と比較して低かった(<0.001). 【結語】大腸癌患者において,術前のCONUTscore>3.0 では,SSI 発生頻度が高く予後不良であった.CONUT を指標に術前患者に対する栄養介入でこれらの改善が可能か検討する必要がある.

15 June 2018 in Journal of Nippon Medical School
Verified
Journal Article
Open access
PDF file
KYKazuhiko Yoshimatsu
Kazuhiko Yoshimatsu
MSMasano Sagawa
Masano Sagawa
HYHajime Yokomizo
Hajime Yokomizo
YYYuki Yano
Yuki Yano
SOSachiyo Okayama
Sachiyo Okayama
YNYoshihiko Naritaka
Yoshihiko Naritaka
Incisional surgical site infection (SSI) is a leading complication of stoma reversal procedures. This retrospective study was conducted to assess the incidence of incisional SSI and other wound complications when wound closure was achieved by subcuticular suturing and closed suction drainage following stoma reversal. We analyzed data from a total of 49 patients, all of whom had undergone insertion of a 10 Fr closed suction drainage tube in the fascia, following irrigation with approximately 300 mL of physiological saline. We then performed subcuticular suturing with 4-0 monofilament absorbable sutures. The median age of our patient population (34 men and 15 women) was 68 (range, 35-84) years. Six patients had an end stoma and 43 had a loop stoma. The wound category was 'contaminated' in 18 patients, while an incisional SSI was observed in one patient (2.0%). No wound disruptions, seromas, or drain infections were evident. Our data are reliable, but our study is limited in terms of general applicability; however, the low SSI rate indicates that the procedure is acceptable. Further research into this procedure will require a randomized trial design.